Fifth disease - Faama'I Lona Lima
https://en.wikipedia.org/wiki/Fifth_disease
☆ AI Dermatology — Free ServiceI le 2022 Stiftung Warentest i'uga mai Siamani, o le fa'amalieina o tagata fa'atau i ModelDerm sa na'o sina maualalo ifo nai lo fa'atalanoaga telemedicine totogi. relevance score : -100.0%
References
Fifth disease (parvovirus B19) 35951969 NIH
Fifth disease , e ta'ua fo'i o le erythema infectiosum, ose fa'ama'i viral e mafua mai le parvovirus B19. E sili atu ona taatele i tamaiti, e masani ona aafia i latou i le va o le 4 i le 14 tausaga. E masani ona amata i le fiva vaivai, ulu tiga, fa'a'i tiga, ma lagona pei o le ful'u. E mafai e tamaiti ona maua se mageso mumu manino i luga o le foliga pei o le 'slapped cheeks', fa'atasi ai ma se mageso mamanu i luga o le tino, lima, ma vae. I tagata matutua, o le tiga o sooga o se fa'asea masani, lea e ono aliali mai i vaiaso pe a mae'a le ma'i muamua. Ae peita'i, i le 20 i le 30% o tagata matutua ua a'afia i le parvovirus B19 atonu e le fa'aalia ni fa'ailoga.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Exposure to fifth disease in pregnancy 20008596 NIH
O le lamatiaga o le pasi atu o le parvovirus B19 mai le tina i le pepe e tusa ma le 33%, ma e tusa ma le 3% o fafine ua aafia o loʻo feagai ma faʻalavelave i lo latou pepe. Pe a pisia le tina i le taimi e le o le 20 vaiaso o le maitaga, e faatupulaia le avanoa e tupu ai faaletonu e pei o le toto ma le faaputuputuina o le suavai i le tino o le pepe. Ina ia amata pulea lenei maʻi, e tatau ona tatou siaki pe na faʻaalia le tagata maʻi i le parvovirus B19 e ala i le suʻega mo le IgM. Afai o le suʻega e leʻi faʻaalia i se taimi ua tuanaʻi ae faʻaalia se faʻamaʻi lata mai, e manaʻomia e le tagata maʻi le mataʻituina lelei i le taimi o le maitaga, e aofia ai suʻesuʻega masani ma le ultrasound e siaki ai i le soifua maloloina o le pepe.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
Fa'ama'i lona lima (fifth disease) e amata i le fiva maualalo, ulu tiga, mageso, ma fa'ailoga e pei o le malulu, pe susu. O nei fa'ailoga e pasi, ona mavae i ni nai aso, ma aliali mai le mageso. O le mageso mumu‑mumu e masani ona aliali i le foliga, aemaise i alafau (o le mea lea o le igoa "faʻamaʻi alafau sasa"). I le faaopoopo atu i alafau mumu, e masani ona tupu se mumu, mageso i luga o le tino atoa, ma i lima, pito i luga, tino, ma vae o nofoaga sili ona fa'asalalau.
O le ma'i e masani lava ona vaivai, ae i fafine ma'i, o le fa'ama'i i le masina muamua e feso'ota'i ma le hydrops fetalis, ma mafua ai ona fa'ato'i fanau.
○ Togafiti
Leai se togafitiga faʻapitoa e manaʻomia; e fautuaina le tausiga masani i le taimi.